Westway Health Team
Project Manager, Aoife McCarthy, BSc, PhD
Aoife has acted as Project Manager at Westway Health since September 2017. Prior to joining the company, Aoife spent 15 years working in R&D, Regulatory Affairs and project management roles in both industrial and academic settings.
She brings to Westway Health a strong background of advancing research to the next stage of product development and commercialisation from her experience working as Project Manager with a Venture Capitalist company. Exploring funding opportunities, and managing deliverables under the H2020 SME Phase 2 project at Westway Health is her focus at present.
Aoife received her 1st class honours undergraduate degree, Bachelor of Science, Chemistry, and PhD from NUI Galway.
Senior Scientist, Cathy Abberton, BSc, MSc
Cathy has been with the company since July 2015 and has played a key role in the development of LARS, focusing on the advancement of the in vitro aspects of the LARS technology and optimisation of the excipient. More recently, she has been investigating PanaMast™ LC administration and dosage regimes in vivo.
She has brought a strong microbiological background to the team, in particular, expertise using both culture-dependant and -independent techniques to investigate the persistence of pathogenic organisms in water systems, biofilms, and other environments. She has developed several key assays within the company, and is responsible for coordinating and delivering a number of critical laboratory studies under the on-going H2020 SME Phase 2 project. Cathy is also responsible for the training and up-skilling of new staff.
Cathy received her honours undergraduate degree, Bachelor of Science, Microbiology, and MSc by Research, Environmental Microbiology, from NUI Galway.
Research Associate, Tara Vollmerhausen, BSc, PhD
Tara began as Research Associate in Westway Health in November 2017 following over 3 years postdoctoral research in NUI Galway. Tara’s past research interests have included investigating novel strategies to treat biofilm-associated infections and their resistance mechanisms. Her role in Westway Health involves exploring the safety and biological effects of the novel LARS technology and PanaMast™ by studying clinical pharmacodynamics and pharmacokinetics to further understand the interactions of the antimicrobial with the body. Tara’s research forms a critical part of the H2020 SME Phase 2 project team.
Tara received her honours undergraduate degree, Bachelor of Science, Medical Microbiology, and her PhD from the University of the Sunshine Coast, Australia.
Research Associate, Samantha Chui-Sang Lee, BSc, PhD
Sam joined the Westway Health team in October 2017 and is involved in advancing the R&D of the LARS technology in animal health under the on-going H2020 SME Phase 2 project. This role involves examining the microbiota of the bovine rumen, made up of a diverse, symbiotic community, and investigating the effect of the LARS technology on that community.
Sam’s research to-date makes use of advancing microbiological and molecular techniques to detect and quantify a wide range of target genes and pathogens. Sam has previously developed and assessed the use of a long-range target RT-qPCR assay to examine the genomic integrity of viral pathogens and its relationship to infectivity before/after UV-treatment.
Sam received her honours undergraduate degree, Bachelor of Science, Genetics and Cell Biology from Dublin City University, and her PhD in Microbiology from NUI Galway.
Research Associate, Camilla Thorn, BSc, PhD
Camilla joined the Westway Health team in November 2017 and brings with her a strong background in microbial ecology, with experience using high-throughput molecular methods to investigate the effects of various stresses upon mixed microbial communities.
Her role at the company involves investigating the potential of using the LARS technology to improve digestive health through their selective action upon certain members of the host gut microbiota. Her studies are directly related to the H2020 SME Phase 2 project.
Camilla received her honours undergraduate degree, Bachelor of Science, Microbiology, and after teaching for a number of years, returned to complete her PhD in Microbial Ecology in NUI Galway.
Research Associate, Conor Larkin, BSc
Conor joined the Westway Health team in July 2017, with his main focus at the company involving research into the use of PanaMast™ as a treatment for mastitis with an emphasis on efficacy testing. This forms a critical part of the current H2020 SME Phase 2 research. He brings a strong work ethic and a good microbiological know-how to the company.
Conor received his 1st class honours undergraduate degree, Bachelor of Science, Microbiology, from NUI Galway.
Research Associate, Martin Gordon, BSc
Martin, in his position as Research Associate at Westway Health, brings a strong microbiological background to the team since joining in September 2017. Martin’s role at the company involves efficacy and biological safety testing of the LARS technology and PanaMast™ – crucial to the H2020 SME Phase 2 project on-going at Westway Health.
Martin graduated from NUI Galway with a 1st class honours Bachelor of Science, Microbiology, and is the current recipient of the Dunican Medal Award.